Oppenheimer Holdings, Inc. (DE) (OPY) News

Oppenheimer Holdings, Inc. (DE) (OPY): $45.21

1.60 (+3.67%)

POWR Rating

Component Grades













Filter OPY News Items

OPY News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

OPY News Highlights

  • OPY's 30 day story count now stands at 21.
  • Over the past 25 days, the trend for OPY's stories per day has been choppy and unclear. It has oscillated between 1 and 6.
  • LAW, III and KT are the most mentioned tickers in articles about OPY.

Latest OPY News From Around the Web

Below are the latest news stories about Oppenheimer Holdings Inc that investors may wish to consider to help them evaluate OPY as an investment opportunity.

Costco Analyst Reviews Mixed Ahead of Earnings Report

Barclays''s Karen Short and Oppenheimer''s Rupesh Parikh say earnings expectations are priced in to Costco stock.

The Street | September 17, 2021

Vaccinex to Present at the Oppenheimer & Co. Inc. Fall Healthcare Life Sciences and MedTech Summit

ROCHESTER, N.Y., Sept. 17, 2021 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology Company pioneering a differentiated approach to treating neurodegenerative disease and cancer through the inhibition of SEMA4D, a potent biological mediator, today announced that Elizabeth Evans, PhD, Chief Operating Officer, is scheduled to present at the Oppenheimer & Co. Inc. Fall Healthcare Life Sciences and MedTech Summit.

Intrado Digital Media | September 17, 2021

Invesco Oppenheimer Funds - 10 Best Invesco Oppenheimer Mutual Funds

Top-Rated Invesco Oppenheimer Funds as of 8/31/21 Fund Name, Ticker, Overall Rating, (Risk Grade) Invesco US Managed Volatility R6 USMVX A+ (C+) Invesco PA Municipal A A (C-) Invesco NJ Muni A A- ...

Yahoo | September 17, 2021

Infinity to Participate in Oppenheimers Fall Healthcare Life Sciences and MedTech Summit and the 3rd Annual Macrophage-directed Therapies Summit

CAMBRIDGE, Mass. --(BUSINESS WIRE)--Sep. 13, 2021-- Infinity Pharmaceuticals, Inc . (NASDAQ: INFI), a clinical-stage biotechnology company developing eganelisib, a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic which addresses a fundamental biologic mechanism

Investors Infinity | September 13, 2021

Motus GI to Present at the Oppenheimer & Co. Inc. Fall Healthcare Summit

FORT LAUDERDALE, Fla., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (Motus GI or the Company), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced today that its management team is scheduled to present at the Oppenheimer & Co. Inc. Fall Healthcare Summit.

Intrado Digital Media | September 13, 2021

Levin Law, P.A. Announces Investigation of Potential Claims on Behalf of Oppenheimer Customers Who Invested in Horizon Private Equity III

SEC Complaint Alleges Horizon Registered Agent John Woods Lured Clients Into Massive Ponzi Scheme The national securities and class action law firm Levin Law, P.A. is investigating potential claims on behalf of Oppenheimer & Co. customers who invested in Horizon []

iCrowdNewswire | September 13, 2021

HORIZON PRIVATE EQUITY III INVESTOR ALERT: Kurta Law Investigates Ponzi Scheme Allegations on Behalf of Investors

NEW YORK, September 13, 2021--Kurta Law is a securities fraud law firm that can help investors who lost money with the alleged Ponzi scheme Horizon Private Equity III.

Yahoo | September 13, 2021

Porcelain that was stolen by Nazis on the Sothebys auction block

A treasure trove of loot plundered by the Nazis for Hitlers personal collection is set to hit the auction block at Sothebys. The 117 pieces of 18th-century Meissen porcelain which form the Oppenheimer collection are currently racking up big advance bids online. The crown jewel a 1727 mantel clock case already has a top bid

New York Post | September 11, 2021

The top-ranked Wall Street analyst sees as much as 65% upside in these stocks

This is one guru worth listening to.

Yahoo | September 8, 2021

Berger Montague Investigates Ponzi Scheme and Potential Violations of Law by John J. Woods and Others Relating to Investments in Horizon Private Equity III, LLC

Philadelphia, Pennsylvania--(Newsfile Corp. - September 8, 2021) - Berger Montague is investigating potential violations of law relating to investments in Horizon Private Equity III, LLC ("Horizon"), promoted and sold by John J. Woods ("Woods") and others associated with him, including Oppenheimer & Co. Inc. The potential claims arise out of an alleged decades-long Ponzi scheme which defrauded more than 400 investors living in 20 states. If you invested in Horizon or have questions ...

Yahoo | September 8, 2021

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 1.6436 seconds.